ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PGNY vs FMS // OPERATING MARGIN

Progyny Inc. (NASDAQ) VS. Fresenius Medical Care AG American (NYSE) • 15-METRIC TALLY: PGNY 6 — FMS 4
▲ OPERATING MARGIN LEADER: FMS
operating-margins
6.60%
operating-margins
13.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PGNY VS. FMS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PGNY FMS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 23.60% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 16.70% 9.90% +6.80 PGNY /roic <GO>
EV/EBITDA & P/E Valuation 20.5x 21.0x -0.50 PGNY /valuation <GO>
Free Cash Flow Yield 8.80% 2.21% +6.59 PGNY /fcf-yield <GO>
Operating Margin ACTIVE 6.60% 13.90% -7.30 FMS /operating-margins <GO>
Net Profit Margin 4.50% 10.90% -6.40 FMS /net-margins <GO>
Revenue Growth (YoY) 10.40% -3.30% +13.70 PGNY /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 8.84 3.74 +5.10 PGNY /balance-sheet <GO>
Piotroski F-Score Quality 7/9 7/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 59.9 50.8 +9.10 PGNY /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.90 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 34.6x 30.5x +4.10 FMS /forward-pe <GO>
Enterprise Scale & Market Cap $2.24B $12.55B -$10.31B FMS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PGNY REV FMS REV PGNY GROSS % FMS GROSS % PGNY FCF FMS FCF
FY 2025 $1.29B — 23.6% — $191.8M —
FY 2024 $1.17B — 21.7% — $173.7M —
FY 2023 $1.09B — — — $188.8M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PGNY // BETA —
FMS // BETA 0.90